Cargando…
Efficient Feeder-Free Episomal Reprogramming with Small Molecules
Genetic reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs) could offer replenishable cell sources for transplantation therapies. To fulfill their promises, human iPSCs will ideally be free of exogenous DNA (footprint-free), and be derived and cultured in chemically define...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3046978/ https://www.ncbi.nlm.nih.gov/pubmed/21390254 http://dx.doi.org/10.1371/journal.pone.0017557 |
_version_ | 1782199010004566016 |
---|---|
author | Yu, Junying Chau, Kevin Fongching Vodyanik, Maxim A. Jiang, Jinlan Jiang, Yong |
author_facet | Yu, Junying Chau, Kevin Fongching Vodyanik, Maxim A. Jiang, Jinlan Jiang, Yong |
author_sort | Yu, Junying |
collection | PubMed |
description | Genetic reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs) could offer replenishable cell sources for transplantation therapies. To fulfill their promises, human iPSCs will ideally be free of exogenous DNA (footprint-free), and be derived and cultured in chemically defined media free of feeder cells. Currently, methods are available to enable efficient derivation of footprint-free human iPSCs. However, each of these methods has its limitations. We have previously derived footprint-free human iPSCs by employing episomal vectors for transgene delivery, but the process was inefficient and required feeder cells. Here, we have greatly improved the episomal reprogramming efficiency using a cocktail containing MEK inhibitor PD0325901, GSK3β inhibitor CHIR99021, TGF-β/Activin/Nodal receptor inhibitor A-83-01, ROCK inhibitor HA-100 and human leukemia inhibitory factor. Moreover, we have successfully established a feeder-free reprogramming condition using chemically defined medium with bFGF and N2B27 supplements and chemically defined human ESC medium mTeSR1 for the derivation of footprint-free human iPSCs. These improvements enabled the routine derivation of footprint-free human iPSCs from skin fibroblasts, adipose tissue-derived cells and cord blood cells. This technology will likely be valuable for the production of clinical-grade human iPSCs. |
format | Text |
id | pubmed-3046978 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-30469782011-03-09 Efficient Feeder-Free Episomal Reprogramming with Small Molecules Yu, Junying Chau, Kevin Fongching Vodyanik, Maxim A. Jiang, Jinlan Jiang, Yong PLoS One Research Article Genetic reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs) could offer replenishable cell sources for transplantation therapies. To fulfill their promises, human iPSCs will ideally be free of exogenous DNA (footprint-free), and be derived and cultured in chemically defined media free of feeder cells. Currently, methods are available to enable efficient derivation of footprint-free human iPSCs. However, each of these methods has its limitations. We have previously derived footprint-free human iPSCs by employing episomal vectors for transgene delivery, but the process was inefficient and required feeder cells. Here, we have greatly improved the episomal reprogramming efficiency using a cocktail containing MEK inhibitor PD0325901, GSK3β inhibitor CHIR99021, TGF-β/Activin/Nodal receptor inhibitor A-83-01, ROCK inhibitor HA-100 and human leukemia inhibitory factor. Moreover, we have successfully established a feeder-free reprogramming condition using chemically defined medium with bFGF and N2B27 supplements and chemically defined human ESC medium mTeSR1 for the derivation of footprint-free human iPSCs. These improvements enabled the routine derivation of footprint-free human iPSCs from skin fibroblasts, adipose tissue-derived cells and cord blood cells. This technology will likely be valuable for the production of clinical-grade human iPSCs. Public Library of Science 2011-03-01 /pmc/articles/PMC3046978/ /pubmed/21390254 http://dx.doi.org/10.1371/journal.pone.0017557 Text en Yu et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Yu, Junying Chau, Kevin Fongching Vodyanik, Maxim A. Jiang, Jinlan Jiang, Yong Efficient Feeder-Free Episomal Reprogramming with Small Molecules |
title | Efficient Feeder-Free Episomal Reprogramming with Small Molecules |
title_full | Efficient Feeder-Free Episomal Reprogramming with Small Molecules |
title_fullStr | Efficient Feeder-Free Episomal Reprogramming with Small Molecules |
title_full_unstemmed | Efficient Feeder-Free Episomal Reprogramming with Small Molecules |
title_short | Efficient Feeder-Free Episomal Reprogramming with Small Molecules |
title_sort | efficient feeder-free episomal reprogramming with small molecules |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3046978/ https://www.ncbi.nlm.nih.gov/pubmed/21390254 http://dx.doi.org/10.1371/journal.pone.0017557 |
work_keys_str_mv | AT yujunying efficientfeederfreeepisomalreprogrammingwithsmallmolecules AT chaukevinfongching efficientfeederfreeepisomalreprogrammingwithsmallmolecules AT vodyanikmaxima efficientfeederfreeepisomalreprogrammingwithsmallmolecules AT jiangjinlan efficientfeederfreeepisomalreprogrammingwithsmallmolecules AT jiangyong efficientfeederfreeepisomalreprogrammingwithsmallmolecules |